Alterations of tear neuromediators in dry eye disease

Archives of Ophthalmology

Volumn 129, Issue 8, 2011, Pages 981-986

  Lambiase, Alessandro ^a   Micera, Alessandra ^a,b   Sacchetti, Marta ^a   Cortes, Magdalena ^a   Mantelli, Flavio ^a   Bonini, Stefano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; FLUORESCEIN; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; CORNEA INJURY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MUCOUS MEMBRANE PEMPHIGOID; PARTICIPANT OBSERVATION; PRIORITY JOURNAL; SAMPLING; SCHIRMER TEST; SJOEGREN SYNDROME; SLIT LAMP; TEAR FILM;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; DRY EYE SYNDROMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; NEUROPEPTIDES; SEVERITY OF ILLNESS INDEX; SUBSTANCE P; TEARS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 80051574324     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.200     Document Type: Article

References (36)

1. Beuerman RW, Stern ME. Neurogenic inflammation: a first line of defense for the ocular surface. Ocul Surf. 2005;3(4)(suppl):S203-S206.
2. Goetzl EJ, Sreedharan SP. Mediators of communication and adaptation in the neuroendocrine and immune systems. FASEB J. 1992;6(9):2646-2652.
3. Lambrecht BN. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir Res. 2001;2(3):133-138. (Pubitemid 34187918)
4. De Swert KO, Joos GF. Extending the understanding of sensory neuropeptides. Eur J Pharmacol. 2006;533(1-3):171-181. (Pubitemid 43348345)
5. Mélik-Parsadaniantz S, Rostène W. Chemokines and neuromodulation. J Neuroimmunol. 2008;198(1):62-68.
6. Eskandari F, Webster JI, Sternberg EM. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther. 2003;5(6):251-265. (Pubitemid 37407974)
7. Dartt DA, Kessler TL, Chung E-H, Zieske JD. Vasoactive intestinal peptide-stimulated glycoconjugate secretion from conjunctival goblet cells. Exp Eye Res. 1996;63(1):27-34. (Pubitemid 26258797)
8. Kovács I, Ludány A, Ko&tild;szegi T, et al. Substance P released from sensory nerve endings influences tear secretion and goblet cell function in the rat. Neuropeptides. 2005;39(4):395-402.
9. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75-92.
10. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21(4):221-232.
11. Dartt DA. Regulation of lacrimal gland secretion by neurotransmitters and the EGF family of growth factors. Exp Eye Res. 2001;73(6):741-752. (Pubitemid 34112101)
12. Chung CW, Tigges M, Stone RA. Peptidergic innervation of the primate meibomian gland. Invest Ophthalmol Vis Sci. 1996;37(1):238-245. (Pubitemid 26036536)
13. Springer J, Geppetti P, Fischer A, Groneberg DA. Calcitonin gene-related peptide as inflammatory mediator. Pulm Pharmacol Ther. 2003;16(3):121-130. (Pubitemid 36566510)
14. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201(2):167-180. (Pubitemid 39305095)
15. Hosoi J, Murphy GF, Egan CL, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature. 1993;363(6425): 159-163. (Pubitemid 23147013)
16. Pozo D, Gonzalez-Rey E, Chorny A, Anderson P, Varela N, Delgado M. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders. Peptides. 2007;28(9):1833-1846. (Pubitemid 47361418)
17. Wheway J, Mackay CR, Newton RA, et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med. 2005;202(11):1527- 1538. (Pubitemid 41746599)
18. Groneberg DA, Folkerts G, Peiser C, Chung KF, Fischer A. Neuropeptide Y (NPY). Pulm Pharmacol Ther. 2004;17(4):173-180.
19. Bedoui S, Miyake S, Lin Y, et al. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol. 2003;171(7):3451-3458. (Pubitemid 37254546)
20. Kodali S, Ding W, Huang J, Seiffert K, Wagner JA, Granstein RD. Vasoactive intestinal peptide modulates Langerhans cell immune function. J Immunol. 2004; 173(10):6082-6088. (Pubitemid 39487764)
21. Batbayar B, Nagy G, Kövesi G, Zelles T, Fehér E. Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjögren's syndrome. Arch Oral Biol. 2004;49(7):529-538. (Pubitemid 38583489)
22. Ekström J, Ekman R, Håkanson R, Sjögren S, Sundler F. Calcitonin gene-related peptide in rat salivary glands: neuronal localization, depletion upon nerve stimulation, and effects on salivation in relation to substance P. Neuroscience. 1988; 26(3):933-949.
23. Lodde BM, Mineshiba F, Wang J, et al. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjögren's syndrome. Ann Rheum Dis. 2006;65(2):195-200. (Pubitemid 43131993)
24. Konttinen YT, Hukkanen M, Kemppinen P, et al. Peptide-containing nerves in labial salivary glands in Sjögren's syndrome. Arthritis Rheum. 1992;35(7):815-820.
25. Santavirta N, Konttinen YT, Törnwall J, et al. Neuropeptides of the autonomic nervous system in Sjögren's syndrome. Ann Rheum Dis. 1997;56(12):737-740. (Pubitemid 28064840)
26. Fehér E, Zelles T, Nagy G. Immunocytochemical localisation of neuropeptide- containing nerve fibres in human labial glands. Arch Oral Biol. 1999;44 (suppl 1):S33-S37. (Pubitemid 29292938)
27. Lee HK, Lee KS, Kim HC, Lee SH, Kim EK. Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis. Am J Ophthalmol. 2005;139(6):965-971.
28. Lambiase A, Micera A, Pellegrini G, et al. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression. Invest Ophthalmol Vis Sci. 2009;50(10):4622-4630.
29. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):108-152.
30. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5(2):163-178.
31. Mantelli F, Tiberi E, Micera A, Lambiase A, Visintini F, Bonini S. MUC5AC overexpression in tear film of neonates. Graefes Arch Clin Exp Ophthalmol. 2007; 245(9):1377-1381. (Pubitemid 47278674)
32. Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci. 2000;41(5):1063-1069. (Pubitemid 30187542)
33. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res. 2004; 78(3):409-416. (Pubitemid 38183319)
34. Benítez-del-Castillo JM, Acosta MC, Wassfi MA, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007;48(1): 173-181. (Pubitemid 47251400)
35. Mantelli F, Argüeso P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol. 2008;8(5):477-483.
36. Nguyen DH, Beuerman RW, Thompson HW, DiLoreto DA. Growth factor and neurotrophic factor mRNA in human lacrimal gland. Cornea. 1997;16(2):192-199. (Pubitemid 27131583)